SFX by Ex Libris Inc.

Title:	Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study
Source:	Science [0036-8075] Smith, M W yr:1997

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Paxton, W A A. "HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5." Nature 381.6584 (1996): 667-73.
description	2.	Just, J J J. "Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome: a review of the literature examining associations with HLA [corrected]." Human immunology 44.3: 156-169.
description	3.	JOWETT, J. "THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VPR GENE ARRESTS INFECTED T-CELLS IN THE G(2)+M PHASE OF THE CELL-CYCLE." Journal of virology 69.10 (1995): 6304-6313.
description	4.	Kostrikis, L G G. "A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation." Nature medicine 4.3 (1998): 350-3.
description	5.	Koup, R A A. "A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness." The journal of infectious diseases 178.4 (1998): 1163-6.
description	6.	Deng, H R. "Identification of a major co-receptor for primary isolates of HIV-1." Nature 381.6584 (1996): 661-6.
description	7.	Feng, Y. "HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor." Science 272.5263 (1996): 872-7.
description	8.	D'Andrea, A. "Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes." The journal of immunology 155.5 (1995): 2306-10.
description	9.	Garred, P. "Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group." The lancet 349.9069 (1997): 1884-1884.
description	10.	Sheppard, Haynes W W. "HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion." Journal of acquired immune deficiency syndromes 29.3 (2002): 307-13.
description	11.	Refaeli, Y. "The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product." Proceedings of the National Academy of Sciences of the United States of America 92.8 (1995): 3621-5.
description	12.	Lewis, J E E. "HIV/AIDS risk in heterosexual college students. A review of a decade of literature." Journal of American college health 45.4 (1996): 147-58.
description	13.	Delfraissy, I. "Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group." AIDS 11.11 (1997): -8.
description	14.	Cohen, O J J. "Host factors in the pathogenesis of HIV disease." Immunological reviews 159.1 (1997): 31-48.
description	15.	Kiecolt-Glaser, J K K. "Methodological issues in behavioral immunology research with humans." Brain, behavior, and immunity 2.1 (1988): 67-78.
description	16.	Feng, Y. "Inhibition of CCR5-dependent HIV-1 infection by hairpin ribozyme gene therapy against CC-chemokine receptor 5." Virology 276.2: 271-278.
description	17.	Michael, N L L. "The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression." Nature medicine 3.10 (1997): 1160-2.
description	18.	Rolfe, Mark. "Ubiquitin and the Biology of the Cell." Nature medicine 4.11 (1998): 1326-1326.
description	19.	Lusso, P. "Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells." Science 270.5243 (1996): 1811-5.
description	20.	Murphy, D H A. "CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS)." Lancet, The 352.9131 (1998): 866-70.